ADVANZ PHARMA: Alvotech and Advanz Pharma Sign Commercialization Agreement for Proposed Biosimilar to Eylea LD/HD in Europe
Alvotech and Advanz Pharma announced that the companies have entered into an exclusive partnership agreement regarding the supply and commercialization of Alvotech's proposed biosimilar to Eylea®.
Read full article »
Advanz Pharma is an England-based pharmaceutical company that distributes drugs in therapeutic areas such as anti-infectives and endocrinology.
Read more